Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    April 2018
  1. LAI SW, Lai HC, Lin CL, Liao KF, et al
    Proton pump inhibitors and risk of gastric cancer in a case-control study.
    Gut. 2018 Apr 16. pii: gutjnl-2018-316371. doi: 10.1136/gutjnl-2018-316371.
    PubMed     Text format    


  2. WAN QY, Wu XT, Li N, Du L, et al
    Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants.
    Gut. 2018 Apr 3. pii: gutjnl-2018-316416. doi: 10.1136/gutjnl-2018-316416.
    PubMed     Text format    


    March 2018
  3. COOK MB, Coburn SB, Lam JR, Taylor PR, et al
    Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.
    Gut. 2018;67:418-529.
    PubMed     Text format     Abstract available


    February 2018
  4. PENG YC, Huang LR, Lin CL, Hsu WY, et al
    Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.
    Gut. 2018 Feb 22. pii: gutjnl-2018-316057. doi: 10.1136/gutjnl-2018-316057.
    PubMed     Text format    


  5. FERREIRA RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, et al
    Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota.
    Gut. 2018;67:226-236.
    PubMed     Text format     Abstract available


    January 2018
  6. LATERZA L, Scaldaferri F, Gasbarrini A
    Risk factors for gastric cancer: is it time to discard PPIs?
    Gut. 2018 Jan 13. pii: gutjnl-2017-315621. doi: 10.1136/gutjnl-2017-315621.
    PubMed     Text format    


  7. RUGGE M, Meggio A, Pravadelli C, Barbareschi M, et al
    Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
    Gut. 2018 Jan 6. pii: gutjnl-2017-314600. doi: 10.1136/gutjnl-2017-314600.
    PubMed     Text format     Abstract available


  8. SUISSA S, Suissa A
    Proton-pump inhibitors and increased gastric cancer risk: time-related biases.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315729. doi: 10.1136/gutjnl-2017-315729.
    PubMed     Text format    


    December 2017
  9. NIIKURA R, Hayakawa Y, Hirata Y, Yamada A, et al
    Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis.
    Gut. 2017 Dec 22. pii: gutjnl-2017-315710. doi: 10.1136/gutjnl-2017-315710.
    PubMed     Text format    


  10. SUZUKI H, Matsuzaki J
    Helicobacter pylori eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk.
    Gut. 2017 Dec 15. pii: gutjnl-2017-315698. doi: 10.1136/gutjnl-2017-315698.
    PubMed     Text format    


    November 2017
  11. GUETA I, Halkin H, Markovits N, Loebstein R, et al
    Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12.
    Gut. 2017 Nov 28. pii: gutjnl-2017-315695. doi: 10.1136/gutjnl-2017-315695.
    PubMed     Text format    


  12. WALDUM HL, Fossmark R
    Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man.
    Gut. 2017 Nov 20. pii: gutjnl-2017-315629. doi: 10.1136/gutjnl-2017-315629.
    PubMed     Text format    



  13. Erratum: Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.
    Gut. 2017;66:2012.
    PubMed     Text format    


    October 2017
  14. CHEUNG KS, Chan EW, Wong AYS, Chen L, et al
    Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.
    Gut. 2017 Oct 31. pii: gutjnl-2017-314605. doi: 10.1136/gutjnl-2017-314605.
    PubMed     Text format     Abstract available


    September 2017
  15. CHEN IF, Liu KW, Tang TQ, Wang WL, et al
    An unusual gastric tumour with gastric outlet obstruction.
    Gut. 2017 Sep 28. pii: gutjnl-2017-315087. doi: 10.1136/gutjnl-2017-315087.
    PubMed     Text format    


  16. YAN C, Zhu M, Huang T, Yu F, et al
    Genome-wide association studies identified loci contribute to phenotypic variance of gastric cancer.
    Gut. 2017 Sep 22. pii: gutjnl-2017-315230. doi: 10.1136/gutjnl-2017-315230.
    PubMed     Text format    


    August 2017
  17. RAJENDRAN S, Benna C, Monticelli H, Spiro G, et al
    Germline variation of circadian pathway genes and prognosis of gastric cancer patients.
    Gut. 2017 Aug 8. pii: gutjnl-2017-314740. doi: 10.1136/gutjnl-2017-314740.
    PubMed     Text format    


  18. COKER OO, Dai Z, Nie Y, Zhao G, et al
    Mucosal microbiome dysbiosis in gastric carcinogenesis.
    Gut. 2017 Aug 1. pii: gutjnl-2017-314281. doi: 10.1136/gutjnl-2017-314281.
    PubMed     Text format     Abstract available


    June 2017
  19. HUANG LY, Wang X, Cui XF, Li H, et al
    IRTKS is correlated with progression and survival time of patients with gastric cancer.
    Gut. 2017 Jun 24. pii: gutjnl-2016-313478. doi: 10.1136/gutjnl-2016-313478.
    PubMed     Text format     Abstract available


    May 2017
  20. SIERRA JC, Asim M, Verriere TG, Piazuelo MB, et al
    Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.
    Gut. 2017 May 4. pii: gutjnl-2016-312888. doi: 10.1136/gutjnl-2016-312888.
    PubMed     Text format     Abstract available


  21. THOMPSON ED, Zahurak M, Murphy A, Cornish T, et al
    Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.
    Gut. 2017;66:794-801.
    PubMed     Text format     Abstract available


    April 2017
  22. WANG Z, Dai J, Hu N, Miao X, et al
    Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.
    Gut. 2017;66:581-587.
    PubMed     Text format     Abstract available


    March 2017
  23. ZHANG X, Xu W
    Neutrophils diminish T-cell immunity to foster gastric cancer progression: the role of GM-CSF/PD-L1/PD-1 signalling pathway.
    Gut. 2017 Mar 27. pii: gutjnl-2017-313923. doi: 10.1136/gutjnl-2017-313923.
    PubMed     Text format    


  24. WANG TT, Zhao YL, Peng LS, Chen N, et al
    Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.
    Gut. 2017 Mar 8. pii: gutjnl-2016-313075. doi: 10.1136/gutjnl-2016-313075.
    PubMed     Text format     Abstract available


    December 2016
  25. MAEDA M, Nakajima T, Oda I, Shimazu T, et al
    High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study.
    Gut. 2016 Dec 21. pii: gutjnl-2016-313387. doi: 10.1136/gutjnl-2016-313387.
    PubMed     Text format    


    October 2016
  26. MALFERTHEINER P, Megraud F, O'Morain CA, Gisbert JP, et al
    Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Gut. 2016 Oct 5. pii: gutjnl-2016-312288. doi: 10.1136/gutjnl-2016-312288.
    PubMed     Text format     Abstract available


    September 2016
  27. ZHU S, Soutto M, Chen Z, Peng D, et al
    Helicobacter pylori-induced cell death is counteracted by NF-kappaB-mediated transcription of DARPP-32.
    Gut. 2016 Sep 2. pii: gutjnl-2016-312141. doi: 10.1136/gutjnl-2016-312141.
    PubMed     Text format     Abstract available


    April 2016
  28. KNAPP S
    Gut to lung.
    Gut. 2016;65:544-5.
    PubMed     Text format    


  29. YEH JM, Hur C, Ward Z, Schrag D, et al
    Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
    Gut. 2016;65:563-74.
    PubMed     Text format     Abstract available


    February 2016
  30. RUGGE M, Genta RM, Graham DY, Di Mario F, et al
    Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment.
    Gut. 2016 Feb 29. pii: gutjnl-2015-310846. doi: 10.1136/gutjnl-2015-310846.
    PubMed     Text format    


  31. SUNDARESAN S, Kang AJ, Hayes MM, Choi EK, et al
    Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.
    Gut. 2016 Feb 9. pii: gutjnl-2015-310928. doi: 10.1136/gutjnl-2015-310928.
    PubMed     Text format     Abstract available


  32. ITOI T, Ishii K, Ikeuchi N, Sofuni A, et al
    Prospective evaluation of endoscopic ultrasonography-guided double-balloon-occluded gastrojejunostomy bypass (EPASS) for malignant gastric outlet obstruction.
    Gut. 2016;65:193-5.
    PubMed     Text format    


    November 2015
  33. LANSDORP-VOGELAAR I, Kuipers EJ
    Screening for gastric cancer in Western countries.
    Gut. 2015 Nov 26. pii: gutjnl-2015-310356. doi: 10.1136/gutjnl-2015-310356.
    PubMed     Text format    


  34. LIN SJ, Gagnon-Bartsch JA, Tan IB, Earle S, et al
    Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
    Gut. 2015;64:1721-31.
    PubMed     Text format     Abstract available


    September 2015
  35. HU C, Ni Z, Li BS, Yong X, et al
    hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation.
    Gut. 2015 Sep 14. pii: gutjnl-2015-309322. doi: 10.1136/gutjnl-2015-309322.
    PubMed     Text format     Abstract available


    August 2015
  36. YU J, Li X, Tao Q, Yu XL, et al
    Hypermethylation of ZNF545 is associated with poor prognosis in patients with early-stage hepatocellular carcinoma after thermal ablation.
    Gut. 2015 Aug 19. pii: gutjnl-2015-310258. doi: 10.1136/gutjnl-2015-310258.
    PubMed     Text format    


    July 2015
  37. WANG K, Liang Q, Li X, Tsoi H, et al
    MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome.
    Gut. 2015 Jul 23. pii: gutjnl-2015-309276. doi: 10.1136/gutjnl-2015-309276.
    PubMed     Text format     Abstract available


  38. WEI J, Noto JM, Zaika E, Romero-Gallo J, et al
    Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner.
    Gut. 2015;64:1040-8.
    PubMed     Text format     Abstract available


    June 2015
  39. SUNG H, Yang HH, Hu N, Su H, et al
    Functional annotation of high-quality SNP biomarkers of gastric cancer susceptibility: the Yin Yang of PSCA rs2294008.
    Gut. 2015 Jun 24. pii: gutjnl-2015-310059. doi: 10.1136/gutjnl-2015-310059.
    PubMed     Text format    


  40. HE Y, Wang C, Wang Z, Zhou Z, et al
    Genetic variant PLCE1 rs2274223 and gastric cancer: more to be explored?
    Gut. 2015 Jun 15. pii: gutjnl-2015-309968. doi: 10.1136/gutjnl-2015-309968.
    PubMed     Text format    


    May 2015
  41. WANG SM, Tie J, Wang WL, Hu SJ, et al
    POU2F2-oriented network promotes human gastric cancer metastasis.
    Gut. 2015 May 27. pii: gutjnl-2014-308932. doi: 10.1136/gutjnl-2014-308932.
    PubMed     Text format     Abstract available


  42. PAN KF, Zhang L, Gerhard M, Ma JL, et al
    A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
    Gut. 2015 May 18. pii: gutjnl-2015-309197. doi: 10.1136/gutjnl-2015-309197.
    PubMed     Text format     Abstract available


    December 2014
  43. SCHLAERMANN P, Toelle B, Berger H, Schmidt SC, et al
    A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro.
    Gut. 2014 Dec 24. pii: gutjnl-2014-307949. doi: 10.1136/gutjnl-2014-307949.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: